By John Letzing and Denise Roland

 

ZURICH--Novartis AG said on Wednesday that its fourth-quarter net profit fell 57% compared with the corresponding period a year earlier as the Swiss drug giant's eye-care unit dragged on performance.

Basel-based Novartis said net income fell to $1.05 billion in the quarter ended in December, compared with $2.45 billion in the same period a year earlier.

Revenue dipped 4% to $12.52 billion, the company said. Core net income, which strips out one-time events such as impairments or gains, fell to $2.7 billion from $2.9 billion a year earlier, Novartis said.

Analysts had expected revenue of $12.7 billion and core net income of $2.7 billion.

 

Write to John Letzing at john.letzing@wsj.com and Denise Roland at denise.roland@wsj.com

 

(END) Dow Jones Newswires

January 27, 2016 01:47 ET (06:47 GMT)

Copyright (c) 2016 Dow Jones & Company, Inc.
Novartis (NYSE:NVS)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Novartis Charts.
Novartis (NYSE:NVS)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Novartis Charts.